Corporate News 13-Nov-24
Board of Kaveri Seed Company recommends interim dividend
Of Rs 5 per share
Kaveri Seed Company announced that the Board of Directors of the Company at its meeting held on 13 November 2024, inter alia, have recommended the interim dividend of Rs 5 per equity Share (i.e. 250%) , subject to the approval of the shareholders.
Previous News
Kaveri Seed Company consolidated net profit rises 31.07% in the December 2024 quarter
( Results - Announcements 12-Feb-25 17:45 )
Kaveri Seed Company consolidated net profit rises 398.56% in the December 2022 quarter
( Results - Announcements 24-Jan-23 14:56 )
Kaveri Seed Company consolidated net profit declines 69.07% in the December 2023 quarter
( Results - Announcements 02-Feb-24 15:37 )
Kaveri Seed Company fixes record date for interim dividend
( Market Beat - Reports 13-Nov-24 15:26 )
Kaveri Seed Company consolidated net profit declines 45.31% in the September 2021 quarter
( Results - Announcements 20-Nov-21 15:41 )
Kaveri Seed Company to discuss results
( Corporate News - 05-Feb-25 17:01 )
Kaveri Seed Company to hold AGM
( Corporate News - 17-Aug-23 12:35 )
Kaveri Seed Company reports consolidated net loss of Rs 0.27 crore in the March 2024 quarter
( Results - Announcements 22-May-24 15:19 )
Kaveri Seed Company standalone net profit declines 41.96% in the September 2019 quarter
( Results - Announcements 14-Nov-19 15:55 )
L&T Technology Services Ltd leads losers in 'A' group
( Hot Pursuit - 02-Aug-18 15:00 )
Kaveri Seed Company to announce Quarterly Result
( Corporate News - 03-Nov-20 15:12 )
Other Stories
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Jai Mata Glass to conduct board meeting
02-Jul-25 19:12
Back
Top
